Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.

@article{Huang2011PegylatedIP,
  title={Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.},
  author={Jee-Fu Huang and C. Y. Dai and Ming-Lung Yu and Chung-Feng Huang and C F Huang and Ming-Lun Yeh and Jeng-Fu Yang and Nei-Jen Hou and P L Hsiao and Z. Y. Lin and Shinn-Chern Chen and S. Shin and W P Chuang},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2011},
  volume={31 8},
  pages={1155-62}
}
BACKGROUND/AIMS Pretreatment insulin resistance (IR) is associated with treatment response to peginterferon plus ribavirin (PegIFN/RBV) combination therapy in chronic hepatitis C (CHC) infection. However, the impact of PegIFN/RBV therapy on both IR and β-cell function in CHC patients has rarely been investigated. METHODS A total of 277 non-diabetic… CONTINUE READING